Vaping-associated Pulmonary Illness (VAPI)

As of September 2019, the US Centers for Disease Control (CDC) has reported over 350 cases of vaping-associated pulmonary illness (VAPI) across 36 states. The observed patterns of disease are variable but all have been associated with recent electronic cigarette use or "vaping." Vaping is...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2019-10, Vol.200 (7), p.P13-P14
Main Authors: Carlos, W Graham, Crotty Alexander, Laura E, Gross, Jane E, Dela Cruz, Charles S, Keller, Jonathan M, Pasnick, Susan, Jamil, Shazia
Format: Article
Language:English
Subjects:
Bronchoalveolar Lavage Fluid - cytology
Centers for Disease Control and Prevention, U.S
Electronic cigarettes
Electronic Nicotine Delivery Systems
Health hazards
Humans
Lung diseases
Lung Diseases - diagnosis
Lung Diseases - epidemiology
Lung Diseases - etiology
Lung Diseases - therapy
Nicotine
Tomography, X-Ray Computed
United States - epidemiology
Vaping
Vaping - adverse effects
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As of September 2019, the US Centers for Disease Control (CDC) has reported over 350 cases of vaping-associated pulmonary illness (VAPI) across 36 states. The observed patterns of disease are variable but all have been associated with recent electronic cigarette use or "vaping." Vaping is a word used to describe the use of an electronic system to deliver inhaled drugs, most commonly nicotine and cannabinoids (natural or synthetic forms of marijuana).
ISSN:1073-449X
1535-4970
DOI:10.1164/rccm.2007P13